<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00380484</url>
  </required_header>
  <id_info>
    <org_study_id>BKR-KNAST-06</org_study_id>
    <secondary_id>EudractCT-nr 2006-003013-41</secondary_id>
    <nct_id>NCT00380484</nct_id>
  </id_info>
  <brief_title>Short- and Long Term Growth in Children With Asthma</brief_title>
  <official_title>Short- and Long Term Growth in Children With Asthma Treated With Budesonide or Montelukast</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children´s Clinic, Randers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children´s Clinic, Randers</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess if treatment with budesonide 200 microgram per day
      affects short- or long term growth in children with asthma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When children with asthma are treated with inhaled corticosteroids there is a risk of
      systemic adverse events such as growth suppression. It has been reported that treatment with
      budesonide 200 microgram per day does not affect short term growth in children with asthma.
      The aim of the present study is to assess if an unaffected short term growth means that also
      long term growth will be unaffected.

      Short and long term growth in asthmatic children treated with budesonide will be compared
      with the growth in asthmatic children treated with montelukast.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower leg growth rate</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Height</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Budesonide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Montelukast</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>200µg daily</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Montelukast</intervention_name>
    <description>5 mg daily</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Singulair</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 6-11,

          -  prepubertal,

          -  asthma,

          -  normal weight and height,

          -  informed consent

        Exclusion Criteria:

          -  treatment with systemic/inhaled/intranasal corticosteroids within the last week,

          -  major surgery within 4 weeks,

          -  usage of drugs that significantly inhibit CYP3A4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ole D Wolthers</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Clinic Randers</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Clinic Randers</name>
      <address>
        <city>Randers</city>
        <zip>8900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2006</study_first_submitted>
  <study_first_submitted_qc>September 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2006</study_first_posted>
  <last_update_submitted>February 19, 2008</last_update_submitted>
  <last_update_submitted_qc>February 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

